Announcement of the decision by the Company
for the ex-rights record date of stock dividends.
Date of events
2022/08/12
To which item it meets
paragraph 14
Statement
1.Date of the resolution by the board of directors or shareholders meeting
or decision by the Company:2022/08/12
2.Type of ex-rights or ex-dividend (please enter: "Ex-rights",
"Ex-dividend", or "Ex-rights and dividend"):Ex-rights
3.Type and monetary amount of dividend distribution:
Stock dividends NT$0.50000003 per share of common stock,
(50.000003 shares allotted gratuitously for every thousand
shares).
4.Ex-rights (ex-dividend) trading date:2022/08/30
5.Last date before book closure:2022/08/31
6.Book closure starting date:2022/09/01
7.Book closure ending date:2022/09/05
8.Ex-rights (ex-dividend) record date:2022/09/05
9.Any other matters that need to be specified:
The matters related to this new common share issuance through the increase
of capital by earnings recapitalization, please refer to the
Company's public disclosure and filing of the record date fixed by the
Company for distribution of dividends, bonuses or other benefits.
Attachments
Original Link
Original Document
Permalink
Disclaimer
Excelsior Medical Co. Ltd. published this content on 12 August 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 12 August 2022 06:59:07 UTC.
EXCELSIOR MEDICAL CO., LTD. is a Taiwan-based company principally engaged in the distribution, maintenance and leasing of medical equipment and supplies. The Companyâs principal products include artificial kidneys, hemodialysis blood tubing sets and epidural needles, dialysis liquid medicines and powder medicines, dialysis machines, human erythropoietin, surgery consumable materials, blood bags, plasma replacement machines and beauty medical equipment, among others. The Company is also involved in the production and sales of self-owned soybean milk machines, as well as household air fresheners under the brand name of Coway. The Company mainly operates its businesses in domestic market and overseas markets.